Heterogeneity in the response to n-3 polyunsaturated fatty acids
- PMID: 36943155
- PMCID: PMC10794042
- DOI: 10.1097/MCO.0000000000000930
Heterogeneity in the response to n-3 polyunsaturated fatty acids
Abstract
Purpose of review: A central goal in the study of long chain n-3 polyunsaturated fatty acids (PUFA) is to translate findings from the basic sciences to the population level to improve human health and prevent chronic diseases. A tenet of this vision is to think in terms of precision medicine and nutrition, that is, stratification of individuals into differing groups that will have different needs across the lifespan for n-3 PUFAs. Therefore, there is a critical need to identify the sources of heterogeneity in the human population in the dietary response to n-3 PUFA intervention.
Recent findings: We briefly review key sources of heterogeneity in the response to intake of long chain n-3 PUFAs. These include background diet, host genome, composition of the gut microbiome, and sex. We also discuss the need to integrate data from newer rodent models (e.g. population-based approaches), multi -omics, and analyses of big data using machine learning and data-driven cluster analyses.
Summary: Accounting for vast heterogeneity in the human population, particularly with the use of big data integrated with preclinical evidence, will drive the next generation of precision nutrition studies and randomized clinical trials with long-chain n-3 PUFAs.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Dr. Shaikh has received industry support for several conferences and research related to n-3 and n-7 fatty acids. Richard P. Bazinet has received industrial grants, including those matched by the Canadian government, and/or travel support related to work on brain fatty acid uptake from Arctic Nutrition, Bunge Ltd., Capsoil Technologies, DSM, Fonterra, Mead Johnson, Natures Crops International, Nestec Inc and Pharmavite. Moreover, R.P.B. is on the executive committee of the International Society for the Study of Fatty Acids and Lipids and held a meeting on behalf of fatty acids and cell signaling, both of which rely on corporate sponsorship. R.P.B. has given expert testimony in relation to supplements and the brain.
References
-
- Metherel AH, Bazinet RP. Updates to the n-3 polyunsaturated fatty acid biosynthesis pathway: DHA synthesis rates, tetracosahexaenoic acid and (minimal) retroconversion. Prog Lipid Res. 2019;76:101008. - PubMed
-
- de Groot RHM, Meyer BJ. ISSFAL Official Statement Number 6: The importance of measuring blood omega-3 long chain polyunsaturated fatty acid levels in research. Prostaglandins Leukot Essent Fatty Acids. 2020;157:102029. - PubMed
-
This article makes a strong point on why there is tremendous variability in the population in RCTs with EPA/DHA including inappropriate dosing and measurements.
-
- Yuzyuk T, Lozier B, Schwarz EL, Viau K, Kish-Trier E, De Biase I. Intra-individual variability of long-chain fatty acids (C12-C24) in plasma and red blood cells. Prostaglandins Leukot Essent Fatty Acids. 2018;135:30–8. - PubMed
-
- von Schacky C, Kuipers RS, Pijl H, Muskiet FAJ, Grobbee DE. Omega-3 fatty acids in heart disease-why accurately measured levels matter. Neth Heart J. 2023. - PMC - PubMed
-
This article makes a critical point about the clinical utility of the RBC index for measuring EPA/DHA and its important role in randomized clinical trials.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
